U.S. markets closed

Array Technologies, Inc. (ARRY)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
47.11-0.32 (-0.67%)
At close: 1:00PM EST
Sign in to post a message.
  • Y
    Yahoo Finance Insights
    Array BioPharma reached an all time high at 49.97
  • A
    Alexander
    new investor here 👋
    Bullish
  • F
    Florian
    Will it finally attract some attention? Still convinced that this is a gem, but we certainly need more awareness amongst institutional buyers.
  • E
    Erik
    Anyone read this line on the earnings call transcript?:

    "we will be announcing, in very short order, a large deal with a very strategic customer that includes not only domestic but international growth as well"

    Pretty good sign! Looks like plan to be announced next week.
  • l
    luis
    two of my fav stocks that for sure are going to go up ARRY and TAAT. huge news coming up 🚀🚀🚀🚀 Any other stocks you guys recommend let me know plz
    Bullish
  • A
    Alexander
    I don't like this phrase, but "to the moon". Heh, patience pays off. Waiting for a steady growth over the next 3 months
  • A
    Arion
    nice
    Bullish
  • d
    drewb
    OUTSTANDING earnings just out!

    Results for the Nine Months Ended September 30, 2020

    Revenues increased 64% to $692.1 million, compared to $423.2 million for the prior-year period driven by increases in the volume of trackers delivered.

    Gross profit increased 86% to $167.3 million, compared to $90.2 million in the prior year period driven primarily by higher revenues. Gross margin increased to 24.2% from 21.3% in the prior year period driven by reductions in purchased materials resulting from improved supplier arrangements and shifting volumes for certain components to new, lower cost suppliers and greater leverage on fixed costs from higher sales volumes.

    Operating expenses increased to $69.9 million compared to $47.3 million during the same period in the prior year primarily as a result of a $13.6 million non-cash charge in the third quarter related to the revaluation of certain earn-out obligations we have to our founder and approximately $1.8 million of professional fees related to our recapitalization and initial public offering.

    Income from operations increased 127% to $97.5 million, compared to $42.9 million during the same period in the prior year.

    Net income increased 431% to $68.8 million, compared to $13.0 million during the same period in the prior year and basic and diluted income per share was $0.57 compared to $0.11 during the same period in the prior year. Adjusted net income increased 116% to $93.4 million, compared to $43.2 million during the same period in the prior year and adjusted net income per share was $0.78 compared to $0.36 during the same period in the prior year.

    Adjusted EBITDA increased 96% to $140.5 million, compared to $71.8 million for the prior-year period.
  • C
    Corky
    Does anyone here know when the lockup expiration is on ARRY? I've Google searched, as I do for any stock, and found nothing about that.
  • d
    devon
    Holding! Not sure how this hasn’t picked up yet .. definitely under valued
  • E
    Eddy
    Will go to moon now as Biden wins????!!
    Bullish
  • M
    MaverickXXX
    So I guess the "we will be announcing, in very short order, a large deal with a very strategic customer that includes not only domestic but international growth as well" is this one which was announced this morning.
    https://finance.yahoo.com/quote/ARRY/?p=ARRY
  • D
    Dennis
    Wild ride but has huge potential.
  • R
    Ron
    Should I buy now?
  • Y
    Yahoo Finance Insights
    Array BioPharma is down 14.29% to 36.00
  • J
    Jianguo
    What to expect after its financial release after the close of today's session? Any thought, any one? Thanks.
  • J
    Jianguo
    I just read the quarterly report: beyond my optimistic expectation. However, the price action for the after market is perplexing. Any thought? Thanks.
  • M
    Muresan
    i dont like the situation on last q3 2020 139m rev, with q3 2019 197mrev, and the q4 2020 sems like 150-160 mil rev expected, 2020 q1 +q2 = 560 milion revenue, so something hapened in q3 ... first view
    Neutral
  • A
    Alexander
    Shorted. Want to buy at better price:) But it may still go up with Biden. Watch
  • A
    Alexander
    May go up to 50, only if Biden wins.
    Bullish